No Picture
News

Newlab and Ørsted Launch the Blue Energy Studio to Power Renewable Energy Innovation

NEW YORK–(BUSINESS WIRE)–Newlab, a community of experts and innovators applying transformative technology to solve the world’s biggest challenges, and Ørsted, the global leader in offshore wind development, announced the launch of the Blue Energy Stu… […]

No Picture
News

Inscopix Unveils First Demonstration of Optical-based ‘Wearable’ for Real-Time Measurement of Brain Activity in Non-Human Primates

PALO ALTO, Calif.–(BUSINESS WIRE)–This research advances the understanding of brain health & the development of next-gen precision therapeutics & brain-computer interfaces. […]

No Picture
News

SiMa.ai and The University of Tübingen Collaborate to Accelerate Low-Power Artificial Intelligence at the Embedded Edge While Reducing AI Compute Carbon Footprint

SAN JOSE, Calif.–(BUSINESS WIRE)– #AI–SiMa.ai announced today its joint collaboration with the Department for Computer Science at the University of Tübingen in the Hardware-Agnostic Artificial Intelligence for Embedded project. Through this importan… […]

No Picture
News

Israel’s VBL Therapeutics hit with CMC delays in ovarian cancer study; Novo Holdings buys out diagnostics player BBI

VBL Therapeutics has hit a roadblock in its Phase III study for platinum-resistant ovarian cancer. Batches of the VB-111 compound being evaluated in the study are still being reviewed by the FDA’s CMC group, the company announced Tuesday, with regulato… […]

No Picture
News

Acclivity Health and Vytalize Health Partner to Improve Care for Palliative Patients

JACKSONVILLE, Fla.: JACKSONVILLE, Fla., June 15, 2021 /PRNewswire/ — Acclivity Health, a trusted technology innovator in transforming care for the seriously ill, today announced a partnership with Vytalize Health, a leading provider of value-based hea… […]

No Picture
News

PulmoSIM Therapeutics Granted Orphan Drug Designation for PT001 by the FDA to Treat Pulmonary Arterial Hypertension

SAN FRANCISCO–(BUSINESS WIRE)– #PAH–PulmoSIM Therapeutics (PulmoSIM), the pharmaceutical subsidiary of VeriSIM Life, Inc., is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for asset PT001 fo… […]